The Cicada Vaccine Forecasting Engine and Guide
0.1.0 - ci-build
The Cicada Vaccine Forecasting Engine and Guide - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: http://fhirfli.dev/fhir/ig/cicada/ConceptMap/Icd10ToCdsiObservation | Version: 0.1.0 | |||
| Active as of 2026-09-07 | Computable Name: Icd10ToCdsiObservation | |||
Maps ICD-10-CM codes to CDSi observation codes used in immunization decision support. Generated from the cicada crosswalk.
Mapping from Vaccine Condition Codes (ICD-10-CM) to CDSI Observation Codes Value Set
Mapping from ICD-10-CM (external, content not present) to CDSI Observation Codes
| Source Code | Relationship | Target Code |
| D84.9 (Immunodeficiency, unspecified) | is equivalent to | 003 (Immunocompromised) |
| D83.9 (Common variable immunodeficiency, unspecified) | is equivalent to | 003 (Immunocompromised) |
| D80.9 (Immunodeficiency with predominantly antibody defects, unspecified) | is equivalent to | 003 (Immunocompromised) |
| D89.9 (Disorder involving the immune mechanism, unspecified) | is equivalent to | 003 (Immunocompromised) |
| D84.8 (Other specified immunodeficiencies) | is equivalent to | 003 (Immunocompromised) |
| Z94.84 (Stem cells transplant status) | is equivalent to | 004 (Recipient of a hematopoietic stem cell transplant) |
| T86.00 (Unspecified complication of bone marrow transplant) | is equivalent to | 004 (Recipient of a hematopoietic stem cell transplant) |
| T86.09 (Other complications of bone marrow transplant) | is equivalent to | 004 (Recipient of a hematopoietic stem cell transplant) |
| B18.2 (Chronic viral hepatitis C) | is equivalent to | 005 (Hepatitis C virus infection) |
| B17.10 (Acute hepatitis C without hepatic coma) | is equivalent to | 005 (Hepatitis C virus infection) |
| B17.11 (Acute hepatitis C with hepatic coma) | is equivalent to | 005 (Hepatitis C virus infection) |
| B19.20 (Unspecified viral hepatitis C without hepatic coma) | is equivalent to | 005 (Hepatitis C virus infection) |
| D66 (Hereditary factor VIII deficiency) | is equivalent to | 006 (Receives clotting factor concentrates) |
| D67 (Hereditary factor IX deficiency) | is equivalent to | 006 (Receives clotting factor concentrates) |
| D68.2 (Hereditary deficiency of other clotting factors) | is equivalent to | 006 (Receives clotting factor concentrates) |
| Z33.1 (Pregnant state, incidental) | is equivalent to | 007 (Pregnant) |
| O09.90 (Supervision of high risk pregnancy, unspecified, unspecified trimester) | is equivalent to | 007 (Pregnant) |
| Z34.00 (Encounter for supervision of normal first pregnancy, unspecified trimester) | is equivalent to | 007 (Pregnant) |
| Z34.80 (Encounter for supervision of other normal pregnancy, unspecified trimester) | is equivalent to | 007 (Pregnant) |
| Z39.1 (Encounter for care and examination of lactating mother) | is equivalent to | 009 (Breastfeeding) |
| G96.00 (Cerebrospinal fluid leak, unspecified) | is equivalent to | 010 (Cerebrospinal fluid leaks) |
| G96.01 (Cranial cerebrospinal fluid leak, spontaneous) | is equivalent to | 010 (Cerebrospinal fluid leaks) |
| G96.02 (Spinal cerebrospinal fluid leak, spontaneous) | is equivalent to | 010 (Cerebrospinal fluid leaks) |
| G96.08 (Other cranial cerebrospinal fluid leak) | is equivalent to | 010 (Cerebrospinal fluid leaks) |
| G96.09 (Other spinal cerebrospinal fluid leak) | is equivalent to | 010 (Cerebrospinal fluid leaks) |
| Z96.21 (Cochlear implant status) | is equivalent to | 011 (Cochlear implants) |
| Z83.2 (Family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism) | is equivalent to | 012 (Family history of altered immunocompetence) |
| D81.9 (Combined immunodeficiency, unspecified) | is equivalent to | 013 (Severe Combined Immunodeficiency [SCID]) |
| D81.0 (Severe combined immunodeficiency [SCID] with reticular dysgenesis) | is equivalent to | 013 (Severe Combined Immunodeficiency [SCID]) |
| D81.1 (Severe combined immunodeficiency [SCID] with low T- and B-cell numbers) | is equivalent to | 013 (Severe Combined Immunodeficiency [SCID]) |
| D81.2 (Severe combined immunodeficiency [SCID] with low or normal B-cell numbers) | is equivalent to | 013 (Severe Combined Immunodeficiency [SCID]) |
| D81.3 (Adenosine deaminase [ADA] deficiency) | is equivalent to | 013 (Severe Combined Immunodeficiency [SCID]) |
| D81.5 (Purine nucleoside phosphorylase [PNP] deficiency) | is equivalent to | 013 (Severe Combined Immunodeficiency [SCID]) |
| D81.6 (Major histocompatibility complex class I deficiency) | is equivalent to | 013 (Severe Combined Immunodeficiency [SCID]) |
| D81.7 (Major histocompatibility complex class II deficiency) | is equivalent to | 013 (Severe Combined Immunodeficiency [SCID]) |
| E10.9 (Type 1 diabetes mellitus without complications) | is equivalent to | 014 (Diabetes) |
| E10.65 (Type 1 diabetes mellitus with hyperglycemia) | is equivalent to | 014 (Diabetes) |
| E11.9 (Type 2 diabetes mellitus without complications) | is equivalent to | 014 (Diabetes) |
| E11.65 (Type 2 diabetes mellitus with hyperglycemia) | is equivalent to | 014 (Diabetes) |
| E13.9 (Other specified diabetes mellitus without complications) | is equivalent to | 014 (Diabetes) |
| E08.9 (Diabetes mellitus due to underlying condition without complications) | is equivalent to | 014 (Diabetes) |
| E09.9 (Drug or chemical induced diabetes mellitus without complications) | is equivalent to | 014 (Diabetes) |
| K70.30 (Alcoholic cirrhosis of liver without ascites) | is equivalent to | 015 (Chronic liver disease) |
| K70.31 (Alcoholic cirrhosis of liver with ascites) | is equivalent to | 015 (Chronic liver disease) |
| K73.9 (Chronic hepatitis, unspecified) | is equivalent to | 015 (Chronic liver disease) |
| K74.0 (Hepatic fibrosis) | is equivalent to | 015 (Chronic liver disease) |
| K74.60 (Unspecified cirrhosis of liver) | is equivalent to | 015 (Chronic liver disease) |
| K74.69 (Other cirrhosis of liver) | is equivalent to | 015 (Chronic liver disease) |
| K76.0 (Fatty (change of) liver, not elsewhere classified) | is equivalent to | 015 (Chronic liver disease) |
| K76.9 (Liver disease, unspecified) | is equivalent to | 015 (Chronic liver disease) |
| I25.10 (Atherosclerotic heart disease of native coronary artery without angina pectoris) | is equivalent to | 016 (Chronic heart disease) |
| I25.9 (Chronic ischemic heart disease, unspecified) | is equivalent to | 016 (Chronic heart disease) |
| I50.9 (Heart failure, unspecified) | is equivalent to | 016 (Chronic heart disease) |
| I50.20 (Unspecified systolic (congestive) heart failure) | is equivalent to | 016 (Chronic heart disease) |
| I50.30 (Unspecified diastolic (congestive) heart failure) | is equivalent to | 016 (Chronic heart disease) |
| I42.9 (Cardiomyopathy, unspecified) | is equivalent to | 016 (Chronic heart disease) |
| I42.0 (Dilated cardiomyopathy) | is equivalent to | 016 (Chronic heart disease) |
| Q24.9 (Congenital malformation of heart, unspecified) | is equivalent to | 016 (Chronic heart disease) |
| J44.9 (Chronic obstructive pulmonary disease, unspecified) | is equivalent to | 017 (Chronic lung disease) |
| J44.1 (Chronic obstructive pulmonary disease with (acute) exacerbation) | is equivalent to | 017 (Chronic lung disease) |
| J43.9 (Emphysema, unspecified) | is equivalent to | 017 (Chronic lung disease) |
| J84.9 (Interstitial pulmonary disease, unspecified) | is equivalent to | 017 (Chronic lung disease) |
| J84.10 (Pulmonary fibrosis, unspecified) | is equivalent to | 017 (Chronic lung disease) |
| J47.9 (Bronchiectasis, uncomplicated) | is equivalent to | 017 (Chronic lung disease) |
| P27.1 (Bronchopulmonary dysplasia originating in the perinatal period) | is equivalent to | 017 (Chronic lung disease) |
| D73.0 (Hyposplenism) | is equivalent to | 018 (Laboratory Evidence of Immunity or confirmation of Hepatitis A disease) |
| Q89.01 (Asplenia (congenital)) | is equivalent to | 018 (Laboratory Evidence of Immunity or confirmation of Hepatitis A disease) |
| D73.89 (Other diseases of spleen) | is equivalent to | 018 (Laboratory Evidence of Immunity or confirmation of Hepatitis A disease) |
| Z90.81 (Acquired absence of spleen) | is equivalent to | 018 (Laboratory Evidence of Immunity or confirmation of Hepatitis A disease) |
| N18.1 (Chronic kidney disease, stage 1) | is equivalent to | 019 (Laboratory Evidence of Immunity or confirmation of Hepatitis B disease) |
| N18.2 (Chronic kidney disease, stage 2 (mild)) | is equivalent to | 019 (Laboratory Evidence of Immunity or confirmation of Hepatitis B disease) |
| N18.30 (Chronic kidney disease, stage 3 unspecified) | is equivalent to | 019 (Laboratory Evidence of Immunity or confirmation of Hepatitis B disease) |
| N18.4 (Chronic kidney disease, stage 4 (severe)) | is equivalent to | 019 (Laboratory Evidence of Immunity or confirmation of Hepatitis B disease) |
| N18.5 (Chronic kidney disease, stage 5) | is equivalent to | 019 (Laboratory Evidence of Immunity or confirmation of Hepatitis B disease) |
| N18.6 (End stage renal disease) | is equivalent to | 019 (Laboratory Evidence of Immunity or confirmation of Hepatitis B disease) |
| N18.9 (Chronic kidney disease, unspecified) | is equivalent to | 019 (Laboratory Evidence of Immunity or confirmation of Hepatitis B disease) |
| Z99.2 (Dependence on renal dialysis) | is equivalent to | 019 (Laboratory Evidence of Immunity or confirmation of Hepatitis B disease) |
| B20 (Human immunodeficiency virus [HIV] disease) | is equivalent to | 026 (Persons with perinatal HIV infection who do not have evidence of severe immunosuppression and who were vaccinated with MMR before establishment of antiviral therapy [ART]) |
| Z21 (Asymptomatic human immunodeficiency virus [HIV] infection status) | is equivalent to | 026 (Persons with perinatal HIV infection who do not have evidence of severe immunosuppression and who were vaccinated with MMR before establishment of antiviral therapy [ART]) |
| J45.20 (Mild intermittent asthma, uncomplicated) | is equivalent to | 027 (Asthma) |
| J45.30 (Mild persistent asthma, uncomplicated) | is equivalent to | 027 (Asthma) |
| J45.40 (Moderate persistent asthma, uncomplicated) | is equivalent to | 027 (Asthma) |
| J45.50 (Severe persistent asthma, uncomplicated) | is equivalent to | 027 (Asthma) |
| J45.909 (Unspecified asthma, uncomplicated) | is equivalent to | 027 (Asthma) |
| J45.998 (Other asthma) | is equivalent to | 027 (Asthma) |
| K56.1 (Intussusception) | is equivalent to | 028 (Intussusception) |
| K52.9 (Noninfective gastroenteritis and colitis, unspecified) | is equivalent to | 029 (Acute gastroenteritis) |
| A09 (Infectious gastroenteritis and colitis, unspecified) | is equivalent to | 029 (Acute gastroenteritis) |
| A08.0 (Rotaviral enteritis) | is equivalent to | 029 (Acute gastroenteritis) |
| A08.39 (Other viral enteritis) | is equivalent to | 029 (Acute gastroenteritis) |
| R50.9 (Fever, unspecified) | is equivalent to | 030 (Acute febrile illness) |
| A15.0 (Tuberculosis of lung) | is equivalent to | 031 (Tuberculosis) |
| A15.9 (Respiratory tuberculosis unspecified) | is equivalent to | 031 (Tuberculosis) |
| A18.89 (Tuberculosis of other sites) | is equivalent to | 031 (Tuberculosis) |
| A19.9 (Miliary tuberculosis, unspecified) | is equivalent to | 031 (Tuberculosis) |
| R76.11 (Nonspecific reaction to tuberculin skin test without active tuberculosis) | is equivalent to | 031 (Tuberculosis) |
| Z86.11 (Personal history of tuberculosis) | is equivalent to | 031 (Tuberculosis) |
| Z79.82 (Long term (current) use of aspirin) | is equivalent to | 034 (Receiving long-term aspirin therapy) |
| Z11.3 (Encounter for screening for infections with a predominantly sexual mode of transmission) | is equivalent to | 039 (Receives treatment for STD) |
| Z11.4 (Encounter for screening for human immunodeficiency virus [HIV]) | is equivalent to | 039 (Receives treatment for STD) |
| Z20.2 (Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission) | is equivalent to | 039 (Receives treatment for STD) |
| F19.10 (Other psychoactive substance abuse, uncomplicated) | is equivalent to | 040 (Illicit drug use) |
| F14.10 (Cocaine abuse, uncomplicated) | is equivalent to | 040 (Illicit drug use) |
| F11.10 (Opioid abuse, uncomplicated) | is equivalent to | 040 (Illicit drug use) |
| F16.10 (Hallucinogen abuse, uncomplicated) | is equivalent to | 040 (Illicit drug use) |
| F17.210 (Nicotine dependence, cigarettes, uncomplicated) | is equivalent to | 042 (Smoke cigarettes) |
| Z72.0 (Tobacco use) | is equivalent to | 042 (Smoke cigarettes) |
| F10.20 (Alcohol dependence, uncomplicated) | is equivalent to | 043 (Alcoholism) |
| F10.10 (Alcohol abuse, uncomplicated) | is equivalent to | 043 (Alcoholism) |
| Z11.59 (Encounter for screening for other viral diseases) | is equivalent to | 071 (Household contact with hepatitis B surface antigen-positive persons) |
| G31.9 (Degenerative disease of nervous system, unspecified) | is equivalent to | 076 (Progressive neurologic disorder) |
| T50.B95A (Adverse effect of other viral vaccines, initial encounter) | is equivalent to | 077 (Received inactivated or unknown measles vaccine between 1963-1967) |
| Z88.9 (Allergy status to unspecified drugs, medicaments and biological substances) | is equivalent to | 077 (Received inactivated or unknown measles vaccine between 1963-1967) |
| Z91.012 (Allergy to eggs) | is equivalent to | 081 (Severe allergic reaction after previous dose of Polio) |
| T50.A15A (Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter) | is equivalent to | 086 (Severe allergic reaction after previous dose of Pertussis) |
| T50.A95A (Adverse effect of other bacterial vaccines, initial encounter) | is equivalent to | 087 (Severe allergic reaction after previous dose of Diphtheria) |
| T78.1 (Other adverse food reactions, not elsewhere classified) | is equivalent to | 101 (Allergic reaction to egg protein) |
| Z91.018 (Allergy to other foods) | is equivalent to | 102 (Severe allergic reaction to gelatin) |
| T78.40XA (Allergy, unspecified, initial encounter) | is equivalent to | 103 (Severe allergic reaction to arginine) |
| Z91.040 (Latex allergy status) | is equivalent to | 104 (Allergic reaction to latex) |
| Z88.1 (Allergy status to other antibiotic agents) | is equivalent to | 106 (Severe allergic reaction to gentamicin) |
| T36.5X5A (Adverse effect of aminoglycosides, initial encounter) | is equivalent to | 106 (Severe allergic reaction to gentamicin) |
| T36.8X5A (Adverse effect of other systemic antibiotics, initial encounter) | is equivalent to | 109 (Severe allergic reaction to polymyxin B) |
| T78.49XA (Other allergy, initial encounter) | is equivalent to | 111 (Hypersensitivity to the preservative 2-phenoxyethanol) |
| T45.7X5A (Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter) | is equivalent to | 115 (Severe allergic reaction to protamine sulfate) |
| Z88.8 (Allergy status to other drugs, medicaments and biological substances) | is equivalent to | 115 (Severe allergic reaction to protamine sulfate) |
| Z59.00 (Homelessness unspecified) | is equivalent to | 121 (Homelessness) |
| D84.821 (Immunodeficiency due to drugs) | is equivalent to | 142 (Travel to or working in countries that have high or intermediate endemicity of Hepatitis A) |
| C80.0 (Disseminated malignant neoplasm, unspecified) | is equivalent to | 156 (Generalized malignant neoplasm) |
| C80.1 (Malignant (primary) neoplasm, unspecified) | is equivalent to | 156 (Generalized malignant neoplasm) |
| Z94.0 (Kidney transplant status) | is equivalent to | 157 (Solid organ transplantation) |
| Z94.1 (Heart transplant status) | is equivalent to | 157 (Solid organ transplantation) |
| Z94.2 (Lung transplant status) | is equivalent to | 157 (Solid organ transplantation) |
| Z94.4 (Liver transplant status) | is equivalent to | 157 (Solid organ transplantation) |
| Z94.9 (Transplanted organ and tissue status, unspecified) | is equivalent to | 157 (Solid organ transplantation) |
| Z79.52 (Long term (current) use of systemic steroids) | is equivalent to | 158 (Immunosuppressive therapy) |
| Z79.899 (Other long term (current) drug therapy) | is equivalent to | 158 (Immunosuppressive therapy) |
| Z51.0 (Encounter for antineoplastic radiation therapy) | is equivalent to | 159 (Radiation therapy) |
| N18.3 (Chronic kidney disease, stage 3 (moderate)) | is equivalent to | 161 (Chronic kidney disease) |
| N04.9 (Nephrotic syndrome with unspecified morphologic changes) | is equivalent to | 162 (Travel to areas at risk for Yellow Fever transmission) |
| Z51.11 (Encounter for antineoplastic chemotherapy) | is equivalent to | 168 (Chemotherapy) |
| Z51.12 (Encounter for antineoplastic immunotherapy) | is equivalent to | 168 (Chemotherapy) |
| Z04.81 (Encounter for examination and observation of victim following forced sexual exploitation) | is equivalent to | 169 (History of sexual abuse or assault) |
| T74.21XA (Adult sexual abuse, confirmed, initial encounter) | is equivalent to | 169 (History of sexual abuse or assault) |
| T74.22XA (Child sexual abuse, confirmed, initial encounter) | is equivalent to | 169 (History of sexual abuse or assault) |
| Z34.90 (Encounter for supervision of normal pregnancy, unspecified, unspecified trimester) | is equivalent to | 170 (Onset of pregnancy) |
| C95.90 (Leukemia, unspecified not having achieved remission) | is equivalent to | 178 (Leukemia) |
| C91.00 (Acute lymphoblastic leukemia not having achieved remission) | is equivalent to | 178 (Leukemia) |
| C92.00 (Acute myeloblastic leukemia, not having achieved remission) | is equivalent to | 178 (Leukemia) |
| C85.90 (Non-Hodgkin lymphoma, unspecified, unspecified site) | is equivalent to | 179 (Lymphoma) |
| C84.40 (Peripheral T-cell lymphoma, not elsewhere classified, unspecified site) | is equivalent to | 179 (Lymphoma) |
| C81.90 (Hodgkin lymphoma, unspecified, unspecified site) | is equivalent to | 180 (Hodgkin's disease) |
| C90.00 (Multiple myeloma not having achieved remission) | is equivalent to | 181 (Multiple myeloma) |
| C96.9 (Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified) | is equivalent to | 190 (Active treatment for hematologic malignancies) |
| Z59.3 (Problems related to living in residential institution) | is equivalent to | 192 (Severe allergic reaction after previous dose of any egg-based IIV or LAIV influenza vaccine) |
| J84.89 (Other specified interstitial pulmonary diseases) | is equivalent to | 199 (Interstitial lung disease) |
| E84.0 (Cystic fibrosis with pulmonary manifestations) | is equivalent to | 200 (Cystic fibrosis) |
| E84.9 (Cystic fibrosis, unspecified) | is equivalent to | 200 (Cystic fibrosis) |
| I27.0 (Primary pulmonary hypertension) | is equivalent to | 201 (Pulmonary hypertension) |
| I27.20 (Pulmonary hypertension, unspecified) | is equivalent to | 201 (Pulmonary hypertension) |
| I27.9 (Pulmonary heart disease, unspecified) | is equivalent to | 201 (Pulmonary hypertension) |
| F03.90 (Unspecified dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety) | is equivalent to | 202 (Dementia) |
| G30.9 (Alzheimer's disease, unspecified) | is equivalent to | 202 (Dementia) |
| Q90.9 (Down syndrome, unspecified) | is equivalent to | 203 (Down syndrome) |
| E66.9 (Obesity, unspecified) | is equivalent to | 204 (Obesity) |
| E66.01 (Morbid (severe) obesity due to excess calories) | is equivalent to | 204 (Obesity) |
| D56.9 (Thalassemia, unspecified) | is equivalent to | 205 (Thalassemia) |
| D56.0 (Alpha thalassemia) | is equivalent to | 205 (Thalassemia) |
| D56.1 (Beta thalassemia) | is equivalent to | 205 (Thalassemia) |
| I67.9 (Cerebrovascular disease, unspecified) | is equivalent to | 206 (Cerebrovascular disease) |
| I63.9 (Cerebral infarction, unspecified) | is equivalent to | 206 (Cerebrovascular disease) |
| F19.20 (Other psychoactive substance dependence, uncomplicated) | is equivalent to | 207 (Substance use disorder) |
| F99 (Mental disorder, not otherwise specified) | is equivalent to | 208 (Mental Health conditions) |
| L20.9 (Atopic dermatitis, unspecified) | is equivalent to | 223 (Severe allergic reaction after previous dose of orthopoxvirus vaccine) |
| L20.89 (Other atopic dermatitis) | is equivalent to | 223 (Severe allergic reaction after previous dose of orthopoxvirus vaccine) |
| L26 (Exfoliative dermatitis) | is equivalent to | 225 (Household contact with history or presence of atopic dermatitis) |
| L10.9 (Pemphigus, unspecified) | is equivalent to | 225 (Household contact with history or presence of atopic dermatitis) |
| Z20.828 (Contact with and (suspected) exposure to other viral communicable diseases) | is equivalent to | 240 (Healthcare personnel who care for patients infected with less virulent orthopoxviruses (e.g., Vaccinia virus or Cowpox virus)) |
| I51.9 (Heart disease, unspecified) | is equivalent to | 254 (Chronic cardiovascular disease) |
| E66.2 (Morbid (severe) obesity with alveolar hypoventilation) | is equivalent to | 256 (Diabetes mellitus complicated by chronic kidney disease) |
| D75.9 (Disease of blood and blood-forming organs, unspecified) | is equivalent to | 258 (Chronic hematologic disorders) |
| D57.1 (Sickle-cell disease without crisis) | is equivalent to | 259 (Sickle cell disease) |
| D57.00 (Hb-SS disease with crisis, unspecified) | is equivalent to | 259 (Sickle cell disease) |
| R54 (Age-related physical debility) | is equivalent to | 262 (Frailty) |
| E11.40 (Type 2 diabetes mellitus with diabetic neuropathy, unspecified) | is equivalent to | 263 (Diabetes mellitus complicated by neuropathy) |
| E10.40 (Type 1 diabetes mellitus with diabetic neuropathy, unspecified) | is equivalent to | 263 (Diabetes mellitus complicated by neuropathy) |
| E13.40 (Other specified diabetes mellitus with diabetic neuropathy, unspecified) | is equivalent to | 263 (Diabetes mellitus complicated by neuropathy) |
| E11.319 (Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema) | is equivalent to | 264 (Diabetes mellitus complicated by retinopathy) |
| E10.319 (Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema) | is equivalent to | 264 (Diabetes mellitus complicated by retinopathy) |
| E11.69 (Type 2 diabetes mellitus with other specified complication) | is equivalent to | 265 (Diabetes mellitus complicated by end-organ damage) |
| E10.69 (Type 1 diabetes mellitus with other specified complication) | is equivalent to | 265 (Diabetes mellitus complicated by end-organ damage) |
| E13.69 (Other specified diabetes mellitus with other specified complication) | is equivalent to | 265 (Diabetes mellitus complicated by end-organ damage) |
| Z79.4 (Long term (current) use of insulin) | is equivalent to | 266 (Diabetes requiring treatment with insulin) |
| Z94.83 (Pancreas transplant status) | is equivalent to | 267 (Diabetes requiring treatment with sodium-glucose cotransporter-2 (SGLT2) inhibitor) |
| D80.1 (Nonfamilial hypogammaglobulinemia) | is equivalent to | 270 (Severe allergic reaction after previous dose of Chikungunya vaccine) |
| D80.0 (Hereditary hypogammaglobulinemia) | is equivalent to | 270 (Severe allergic reaction after previous dose of Chikungunya vaccine) |
| D84.1 (Defects in the complement system) | is equivalent to | 274 (Early component complement inhibitor use) |
| D58.2 (Other hemoglobinopathies) | is equivalent to | 277 (Laboratory worker with potential for exposure to chikungunya virus) |
| D57.3 (Sickle-cell trait) | is equivalent to | 277 (Laboratory worker with potential for exposure to chikungunya virus) |